Scrip
Among reforms, institute urges a new method of paying for CME in US
05 May 2009
Nancy Faigen
The US Institute of Medicine's Conflict of Interest in Medical Research, Education and Practice committee has issued a far-reaching report outlining how it believes physicians should reject many financial arrangements with pharmaceutical firms. One troublesome area remains industry funding of continuing...
Please Login to read the full article.
05 May 2009
Nancy Faigen
Please Login to read the full article.
RELATED CONTENT
NEWS
- Pfizer funds "new model" of unbiased CME in US with $3 million to Stanford
- US health reform bill: Senate's work may be done, but difficult issues on conference
- US Veterans Administration proposes limits to sales reps' access
- US healthcare reform: painting the future for the pharma industry
COMMENT
Other Informa Comment
FEATURES
- Debate for a new R&D model must start now
- Face-to-Face: Trophos - The French firm that hooked Actelion
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
